J Korean Med Assoc.  2018 Mar;61(3):157-162. 10.5124/jkma.2018.61.3.157.

Smoking cessation services provided by the National Health Insurance Service

• Paek YJ
• Choi JK
• Lee ES
• Jo MW

• KMID: 2406969
• DOI: http://doi.org/10.5124/jkma.2018.61.3.157

Abstract

Smoking cessation services are an important component of preventive medicine. Physicians can help smokers quit smoking by assessing their dependence and motivating them during their clinic visits. Brief advice provided by doctors is a simple and very cost-effective method of smoking cessation. The most effective method of helping smokers stop smoking is combining pharmacotherapy with counseling and behavioral interventions. In early 2015, the National Health Insurance Service started a smokingcessation support program that covered consultation and drug fees across the country. More than 400,000 smokers registered in this program and received assistance from doctors in 2016. The success rate at 6 months after registration was approximately 40%, which is comparable with that of smoking cessation clinics run by public health centers in local areas. Additional efforts are needed to increase the coverage levels of smoking cessation services in Korea.

Keyword

Smoking cessation; National Health Insurance Service; Quit rate

MeSH Terms

Ambulatory Care
Counseling
Drug Therapy
Fees and Charges
Korea
Methods
National Health Programs*
Preventive Medicine
Public Health
Smoke*
Smoking Cessation*
Smoking*
Smoke

Reference

1. Gellert C, Schottker B, Brenner H. Smoking and all-cause mortality in older people: systematic review and meta-analysis. Arch Intern Med. 2012; 172:837–844.

2. Cho HJ. The status and future challenges of tobacco control policy in Korea. J Prev Med Public Health. 2014; 47:129–135.

3. Siu AL. US Preventive Services Task Force. Behavioral and pharmacotherapy interventions for tobacco smoking cessation in adults, including pregnant women: US Preventive Services Task Force Recommendation Statement. Ann Intern Med. 2015; 163:622–634.

4. Seo HG, Cheong YS, Myung SK, Kim Y, Lee WK, Fong GT. Smoking-related characteristics in Korean adult smokers: findings from the 2005 International Tobacco Control Policy Evaluation Survey-Korea. J Korean Acad Fam Med. 2008; 29:844–853.

5. Ferguson J, Bauld L, Chesterman J, Judge K. The English smoking treatment services: one-year outcomes. Addiction. 2005; 100:Suppl 2. 59–69.

6. West R, Owen L. Estimates of 52-week continuous abstinence rates following selected smoking cessation interventions in England [Internet]. London: Smoking in England;2012. cited 2018 Feb 11. Available from: http://www.smokinginengland.info/reports/.

7. Stead LF, Buitrago D, Preciado N, Sanchez G, Hartmann-Boyce J, Lancaster T. Physician advice for smoking cessation. Cochrane Database Syst Rev. 2013; (5):CD000165.

8. Organization for Economic Cooperation and Development. OECD factbook 2015–2016: economic, environmental and social statistics [Internet]. Paris: OECDiLibrary;2016. cited 2018 Feb 11. Available from: http://www.oecd-ilibrary.org/economics/oecd-factbook-2015-2016_factbook-2015-en.

9. Jo MW. Development of smoking cessation treatment pro-gramme and reimbursement system. Seoul: National Health Insurance Service;2015.

10. Choi JK. Research on assesment and development of the pro-ject for support of smoking cessation intervention in 2015. Wonju: National Health Insurance Service;2016.

11. Jo MW. Evaluation of the project for support of smoking cessation intervention in 2016: focus on the patients with chronic disease. Wonju: National Health Insurance Service;2017.

12. Kotz D, Brown J, West R. Effectiveness of varenicline versus nicotine replacement therapy for smoking cessation with minimal professional support: evidence from an English population study. Psychopharmacology (Berl). 2014; 231:37–42.

13. Hsueh KC, Hsueh SC, Chou MY, Pan LF, Tu MS, McEwen A, West R. Varenicline versus transdermal nicotine patch: a 3-year follow-up in a smoking cessation clinic in Taiwan. Psychopharmacology (Berl). 2014; 231:2819–2823.

14. Kotz D, Brown J, West R. ‘Real-world’ effectiveness of smok-ing cessation treatments: a population study. Addiction. 2014; 109:491–499.